2025 MaTOS Breast | Antibody Drug Conjugates (ADCS) to Enhance Anti-Tumor Immune Response

2025 MaTOS Breast | Antibody Drug Conjugates (ADCS) to Enhance Anti-Tumor Immune Response

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Ana C. Garrido-Castro, MD

Date of Release

May 14th, 2025